Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors / Jotanovic, J.; Boldt, H. B.; Burton, M.; Andersen, M. S.; Bengtsson, D.; Bontell, T. O.; Ekman, B.; Engström, B. E.; Feldt-Rasmussen, U.; Heck, A.; Jakovcevic, A.; Jørgensen, J. O. L.; Kraljevic, I.; Kunicki, J.; Lindsay, J. R.; Losa, M.; Loughrey, P. B.; Maiter, D.; Maksymowicz, M.; Manojlovic-Gacic, E.; Pahnke, J.; Petersenn, S.; Petersson, M.; Popovic, V.; Ragnarsson, O.; Rasmussen, Å. K.; Reisz, Z.; Saeger, W.; Schalin-Jäntti, C.; Scheie, D.; Terreni, M. R.; Tynninen, O.; Whitelaw, B.; Burman, P.; Casar-Borota, O.. - In: ACTA NEUROPATHOLOGICA. - ISSN 1432-0533. - 148:1(2024). [10.1007/s00401-024-02836-5]